Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Company Description (as filed with the SEC)
We are a clinical stage biopharmaceutical company developing novel therapies for the management of central nervous system, or CNS, disorders including pain. By focusing on this therapeutic area, we are addressing significant and growing markets where current treatment options are limited or inadequate. Our product candidate portfolio includes two latestage candidates, AXS02 and AXS05, which we are developing for multiple indications. We have initiated a Phase 3 trial with AXS02 in complex regional pain syndrome and plan to initiate a Phase 3 trial in knee osteoarthritis associated with bone marrow lesions in the first quarter of 2016 pursuant to a Special Protocol Assessment, or SPA. We have also initiated a Phase 3 trial with AXS05 in treatment resistant depression. ... More ...
Where does AXSM fit in the risk graph?
|Annual EPS Est:||$|
|Quarterly EPS Est:|